MPN expert Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center explains how doctors assess patients with polycthemia vera (PV) and determine the best treatment for each individual. He explains driver mutations associated with MPNs and how various treatments work to treat the condition. Dr. Verstovsek believes that the most important thing to consider when choosing a therapy is the patient's quality of life.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo